Protocol 2017.008.01: Efficacy and safety of AbGn-168H in patients with moderate to severe active, anti-TNF and/or anti-integrin refractory ulcerative colitis: a 26-week, open-label, multi-center, hase II proof of principle trial
- Hanauer, Stephen B (PD/PI)
Project: Research project